ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 76 filers reported holding ADURO BIOTECH INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $83,000 | +13.7% | 34,241 | +7.9% | 0.01% | -65.9% |
| Q2 2020 | $73,000 | +5.8% | 31,734 | -46.1% | 0.04% | +412.5% |
| Q4 2019 | $69,000 | -70.8% | 58,845 | +209.7% | 0.01% | -38.5% |
| Q3 2016 | $236,000 | -7.1% | 19,000 | -4.0% | 0.01% | -18.8% |
| Q1 2016 | $254,000 | -43.6% | 19,800 | +23.8% | 0.02% | -27.3% |
| Q4 2015 | $450,000 | +89.1% | 16,000 | +30.1% | 0.02% | +83.3% |
| Q3 2015 | $238,000 | – | 12,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 640,595 | $4,708,000 | 1.20% |
| BVF INC/IL | 287,776 | $2,115,000 | 0.19% |
| ORACLE INVESTMENT MANAGEMENT INC | 111,542 | $820,000 | 0.18% |
| Sofinnova Investments, Inc. | 189,579 | $1,393,000 | 0.12% |
| CENTAURUS FINANCIAL, INC. | 85 | $624,000 | 0.11% |
| Artal Group S.A. | 550,000 | $4,043,000 | 0.10% |
| Vident Investment Advisory, LLC | 305,311 | $2,244,000 | 0.09% |
| Virtus ETF Advisers LLC | 61,463 | $452,000 | 0.05% |
| Foundry Partners, LLC | 106,907 | $786,000 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 239,301 | $1,759,000 | 0.02% |